Stockscreener 앱 받기
0.00
100.00%
-76.01
전일 마감가:
$76.01
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$16.97B
수익:
$4.13B
순이익/손실:
$543.90M
주가수익비율:
0.00
EPS:
2.41
순현금흐름:
$957.20M
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
-100.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.00
$0.00
52주 변동 폭
$0.00
$76.07
홀로직 Stock (HOLX) Company Profile
명칭
Hologic Inc
전화
(508) 263-2900
주소
250 CAMPUS DRIVE, MARLBOROUGH, MA
Compare HOLX vs ISRG, BDX, MDLN, ALC, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HOLX
Hologic Inc
|
0.00 | 16.97B | 4.13B | 543.90M | 957.20M | 2.41 |
ISRG
Intuitive Surgical Inc
|
457.79 | 165.27B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
149.04 | 42.53B | 21.92B | 1.76B | 2.63B | 6.1223 |
MDLN
Medline Inc
|
44.42 | 37.41B | 28.43B | 1.16B | 1.26B | 1.4457 |
ALC
Alcon Inc
|
74.87 | 36.75B | 10.40B | 980.00M | 1.61B | 1.9749 |
RMD
Resmed Inc
|
213.81 | 31.63B | 5.40B | 1.49B | 1.78B | 10.12 |
홀로직 Stock (HOLX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-12 | 다운그레이드 | Argus | Buy → Hold |
| 2026-01-05 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2025-11-21 | 다운그레이드 | BNP Paribas Exane | Outperform → Neutral |
| 2025-10-07 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-08-18 | 업그레이드 | Argus | Hold → Buy |
| 2025-08-06 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-07-09 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-05-27 | 재확인 | Needham | Hold |
| 2025-03-03 | 다운그레이드 | Argus | Buy → Hold |
| 2025-02-06 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2025-02-03 | 다운그레이드 | Needham | Buy → Hold |
| 2024-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2024-12-10 | 개시 | Jefferies | Hold |
| 2024-12-10 | 재확인 | Needham | Buy |
| 2024-10-01 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-06-27 | 개시 | Stephens | Overweight |
| 2024-04-03 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-07-14 | 업그레이드 | Needham | Hold → Buy |
| 2022-12-07 | 개시 | RBC Capital Mkts | Sector Perform |
| 2022-10-13 | 개시 | Mizuho | Buy |
| 2022-07-20 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-07-20 | 개시 | UBS | Neutral |
| 2022-07-18 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2022-04-25 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2021-12-15 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-10-14 | 개시 | Redburn | Neutral |
| 2021-07-06 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2020-11-20 | 다운그레이드 | Needham | Buy → Hold |
| 2020-11-05 | 재확인 | Needham | Buy |
| 2020-06-30 | 업그레이드 | Cowen | Market Perform → Outperform |
| 2020-06-03 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-04-30 | 재확인 | Needham | Buy |
| 2020-04-30 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2020-04-07 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2020-03-27 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-13 | 재확인 | Needham | Buy |
| 2020-01-08 | 개시 | Wells Fargo | Equal Weight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2020-01-02 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-09-26 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-08-01 | 재확인 | Needham | Buy |
| 2019-05-02 | 재확인 | Needham | Buy |
| 2019-01-31 | 재확인 | Needham | Buy |
| 2019-01-02 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2018-10-09 | 개시 | UBS | Neutral |
| 2018-09-13 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
모두보기
홀로직 주식(HOLX)의 최신 뉴스
Hologic Stock (US4364401012): Earnings Release Scheduled for Today - AD HOC NEWS
Blackstone & TPG Complete Hologic Acquisition, Appoint Joe Almeida as CEO - Digital Health News
The Official Home of the Women's Tennis Association | WTA Tennis - WTA Tennis
HPV Testing Market Size Expected to Reach $18.6 Billion at 11.2% - openPR.com
Is trending stock Hologic, Inc. (HOLX) a buy now? - MSN
Hologic, Inc. (HOLX) Stock Analysis: Steady Healthcare Innovator with Limited Upside Potential - DirectorsTalk Interviews
Hologic Stock Rises as Report Says Blackstone and TPG in Advanced Takeover Talks - MSN
Blackstone, TPG said to be nearing over $17B deal for Hologic - MSN
Medicinal Microbiology Market Is Going to Boom | Major Giants bioMérieux SA, Hologic, Cepheid - openPR.com
HOLX (Hologic Inc.) posts 1.7 percent year-over-year revenue gain as Q1 2026 EPS misses consensus estimates.Crowd Trend Signals - Cổng thông tin điện tử Tỉnh Sơn La
Interventional Radiology Market is expected to Hit US$ 47.25 - openPR.com
New Evidence Backs Hologic’s AI-Powered Mammography Technology for Detecting Challenging Cancers - 01net
Hologic, Inc. (HOLX) Stock Analysis: Evaluating the Growth Potential in the Medical Instruments Sector - DirectorsTalk Interviews
[15-12G] HOLOGIC INC SEC Filing - Stock Titan
Lobbying Update: $390,000 of HOLOGIC INC. lobbying was just disclosed - Quiver Quantitative
HOLX SEC FilingsHologic Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Anatomic Pathology Market is Expected to Register a CAGR of 7.3% - openPR.com
Biopsy Devices Market Share & Growth: Hologic, Becton Dickinson, and Danaher Leading Precision Diagnostics - openPR.com
[EFFECT] HOLOGIC INC SEC Filing - Stock Titan
Hologic Stock 2026: Buy or Sell HOLX as Blackstone-TPG Buyout Nears Completion With $76 Cash Offer Plus CVR - International Business Times Australia
Sentiment Review: Is Hologic Inc vulnerable to short sellers2026 Catalysts & Safe Entry Trade Signal Reports - baoquankhu1.vn
Hologic: $18.3 Billion Take-Private Deal Completed As Women’s Health MedTech Company Goes Private - Pulse 2.0
Blackstone and TPG Complete Acquisition of Hologic; Names New CEO - MedTech Intelligence
Hologic (HOLX) executive equity awards cancelled and cashed out in merger - Stock Titan
Hologic (HOLX) president exits stock in $76 cash-and-CVR merger - Stock Titan
Merger leaves Hologic (HOLX) executive without any common shares - Stock Titan
Hologic (HOLX) CFO has equity awards cashed out in Hopper merger - Stock Titan
Hologic (HOLX) COO exits equity as merger pays $76 plus CVR per share - Stock Titan
Hologic (HOLX) counsel’s shares converted to $76 cash plus CVR in merger - Stock Titan
Hologic (HOLX) executive equity converted to $76 cash plus CVR in merger - Stock Titan
Hologic (HOLX) SVP stock converted at $76 plus CVR in merger - Stock Titan
Merger cashes out Hologic (HOLX) director Amy McBride’s equity awards - Stock Titan
Hologic (HOLX) director exits equity as merger pays $76 cash plus CVR - Stock Titan
Hologic (HOLX) director exits position as merger pays $76 plus CVRs - Stock Titan
Hologic (HOLX) director surrenders options and shares in cash-and-CVR merger - Stock Titan
Hologic (HOLX) director exits stake as Hopper merger pays cash and CVRs - Stock Titan
Hologic (NASDAQ: HOLX) director equity cashed out in merger - Stock Titan
Hologic (HOLX) CEO exits all company stock as $76 per share buyout closes - Stock Titan
Merger cashes out Hologic (HOLX) director Hantson’s stock and options - Stock Titan
홀로직 (HOLX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.76%
1.34%
자본화:
|
볼륨(24시간):